ABOUT GENE BIOHEALTH

ABOUT GENE BIOHEALTH

关 于 晋 百 慧

Shenzhen GeneBioHealth Co., Ltd (hereinafter “GBH”) is a developer and manufacturer of in-vitro diagnostic medical devices headquartered in Shenzhen, China. GBH was founded by Dr. Haoyang Yu in 2013 and was accredited as " National High and Novel Technology Company " since 2015. With expertise in cancer diagnosis, point of care testing ( POCT ) and human leukocyte antigen ( HLA ) typing.

GBH is dedicated to develop and offer a wide range of products, instruments, services and solutions to our clients. GBH's ultimate goal is to create outstanding value for human health through continuous innovation.
EARLY DETECTION OF TUMOR

EARLY DETECTION OF TUMOR

肿 瘤 早 查

Your guardian of intestinal health!

MiR-92a, a small non-coding RNA, is a newly discovered biomarker with high sensitivity and specificity to CRC. REColonTM miR-92a Assay Kit, the 1st CFDA approved stool-based colorectal cancer diagnostic kit, works through detecting miR-92a level directly from CRC cells shed from lining of human colon and eventually excreted in the stool. By co-working with existing clinical tests, REColonTM serves as an effective tool for CRC screening, early diagnosis and postoperative monitoring.

ABOUT OUR PRODUCT

ABOUT OUR PRODUCT

公 司 产 品

RECOMMEND TO READ

RECOMMEND TO READ

推 荐 阅 读

无创分子诊断技术在肿瘤防治中的应用论坛暨miR-92a检测试剂盒产品发布会圆满落幕

2018年6月15日,由我司主办的“无创分子诊断技术在肿瘤防治中的应用论坛暨miR-92a检测试剂盒(荧光RT-PCR法)产品发布会”在深圳圆满落幕......                     READ MORE >>
About Us
Product
News
Lessons
Service
Telephone:
0755-86573093
Shenzhen GeneBioHealth Co., Ltd
Fax:(+86)755-86573069   E-mail:service@genebiohealth.com   Address:Buliding A9-2F, Tianliao Industrial Park A, Taoyuan Street, Nanshan District, Shenzhen, China
Copyright ©2018 Shenzhen GeneBioHealth Co., Ltd Copyright 粤ICP备15109924号

Follow WeChat